Banerjee Taraswi, Sommers Joshua A, Huang Jing, Seidman Michael M, Brosh Robert M
Laboratory of Molecular Gerontology, National Institute on Aging, NIH, NIH Biomedical Research Center, 251 Bayview Boulevard, Baltimore, MD 21224, USA.
Laboratory of Molecular Gerontology, National Institute on Aging, NIH, NIH Biomedical Research Center, 251 Bayview Boulevard, Baltimore, MD 21224, USA.
Curr Biol. 2015 Nov 2;25(21):2830-2838. doi: 10.1016/j.cub.2015.09.026. Epub 2015 Oct 8.
Three (BLM, WRN, and RECQ4) of the five human RecQ helicases are linked to genetic disorders characterized by genomic instability, cancer, and accelerated aging [1]. RECQ1, the first human RecQ helicase discovered [2-4] and the most abundant [5], was recently implicated in breast cancer [6, 7]. RECQ1 is an ATP-dependent DNA-unwinding enzyme (helicase) [8, 9] with roles in replication [10-12] and DNA repair [13-16]. RECQ1 is highly expressed in various tumors and cancer cell lines (for review, see [17]), and its suppression reduces cancer cell proliferation [14], suggesting a target for anti-cancer drugs. RECQ1's assembly state plays a critical role in modulating its helicase, branch migration (BM), or strand annealing [18, 19]. The crystal structure of truncated RECQ1 [20, 21] resembles that of E. coli RecQ [22] with two RecA-like domains, a RecQ-specific zinc-binding domain and a winged-helix domain, the latter implicated in DNA strand separation and oligomer formation. In addition, a conserved aromatic loop (AL) is important for DNA unwinding by bacterial RecQ [23, 24] and truncated RECQ1 helicases [21]. To better understand the roles of RECQ1, two AL mutants (W227A and F231A) in full-length RECQ1 were characterized biochemically and genetically. The RECQ1 mutants were defective in helicase or BM but retained DNA binding, oligomerization, ATPase, and strand annealing. RECQ1-depleted HeLa cells expressing either AL mutant displayed reduced replication tract length, elevated dormant origin firing, and increased double-strand breaks that could be suppressed by exogenously expressed replication protein A (RPA). Thus, RECQ1 governs RPA's availability in order to maintain normal replication dynamics, suppress DNA damage, and preserve genome homeostasis.
人类五种RecQ解旋酶中的三种(BLM、WRN和RECQ4)与以基因组不稳定、癌症和加速衰老为特征的遗传疾病有关[1]。RECQ1是最早发现的人类RecQ解旋酶[2-4],也是含量最丰富的[5],最近被认为与乳腺癌有关[6,7]。RECQ1是一种ATP依赖性DNA解旋酶[8,9],在复制[10-12]和DNA修复[13-16]中发挥作用。RECQ1在各种肿瘤和癌细胞系中高度表达(综述见[17]),其抑制可降低癌细胞增殖[14],提示其可能是抗癌药物的靶点。RECQ1的组装状态在调节其解旋酶、分支迁移(BM)或链退火方面起着关键作用[18,19]。截短的RECQ1的晶体结构[20,21]类似于大肠杆菌RecQ的结构[22],有两个RecA样结构域、一个RecQ特异性锌结合结构域和一个翼状螺旋结构域,后者与DNA链分离和寡聚体形成有关。此外,一个保守的芳香环(AL)对于细菌RecQ[23,24]和截短的RECQ1解旋酶[21]解开DNA很重要。为了更好地理解RECQ1的作用,对全长RECQ1中的两个AL突变体(W227A和F231A)进行了生化和遗传学表征。RECQ1突变体在解旋酶或BM方面存在缺陷,但保留了DNA结合、寡聚化、ATP酶和链退火能力。表达任一AL突变体的RECQ1缺失的HeLa细胞显示复制片段长度缩短、休眠起始点激活增加以及双链断裂增加,这些可被外源表达的复制蛋白A(RPA)抑制。因此,RECQ1控制RPA的可用性,以维持正常的复制动态、抑制DNA损伤并保持基因组稳态。